EcoDrugPlus

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSCGOG00000020003
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-6-Like

Ensembl ID : ENSCGOG00000001318
Gene Symbol: LOC115015308
2 Cross references
162 Possible Orthologues:

Intermediate Conductance Calcium-Activated Potassium Channel Protein 4-Like

Ensembl ID : ENSCGOG00000015687
Gene Symbol: LOC115021124
2 Cross references
190 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSCGOG00000012407
Gene Symbol: LOC115024775
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSCGOG00000024696
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSCGOG00000009317
Gene Symbol: LOC115025112
3 Cross references
204 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSCGOG00000011490
Gene Symbol: LOC115009706
3 Cross references
196 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSCGOG00000015718
Gene Symbol: LOC115008353
3 Cross references
193 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSCGOG00000021671
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSCGOG00000023197
Gene Symbol: KDR
3 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCGOG00000019868
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSCGOG00000023248
Gene Symbol: KIF5B
3 Cross references
243 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).